Dorsey & Whitney Trust’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,370
Closed -$249K 439
2019
Q2
$249K Sell
2,370
-577
-20% -$58K 0.04% 322
2019
Q1
$311K Sell
2,947
-676
-19% -$67.9K 0.05% 279
2018
Q4
$303K Hold
3,623
0.05% 254
2018
Q3
$369K Sell
3,623
-418
-10% -$40.4K 0.06% 234
2018
Q2
$327K Hold
4,041
0.06% 237
2018
Q1
$298K Hold
4,041
0.05% 246
2017
Q4
$285K Sell
4,041
-25
-0.6% -$1.8K 0.05% 248
2017
Q3
$254K Hold
4,066
0.05% 259
2017
Q2
$233K Hold
4,066
0.05% 274
2017
Q1
$248K Buy
+4,066
New +$230K 0.05% 258

Other funds holding NGVT

Dorsey & Whitney Trust's NGVT Position: Q3 2019 in Review

Dorsey & Whitney Trust sold out of Ingevity (NGVT) in Q3 2019, closing a stake of 2,370 shares — an estimated $249K sold.

Dorsey & Whitney Trust first reported a position in NGVT in Q1 2017 and held it in 10 quarters. The position peaked at $369K in Q3 2018. 335 funds tracked by Wall St. Rank hold NGVT as of Q3 2019.

  • Dorsey & Whitney Trust reported no remaining Ingevity position as of Q3 2019 after selling out during the quarter.
  • Dorsey & Whitney Trust sold 2,370 Ingevity shares in Q3 2019, an estimated $249K.
  • Dorsey & Whitney Trust first reported a position in Ingevity in Q1 2017 and held it in 10 quarters.
  • Dorsey & Whitney Trust's Ingevity position peaked at $369K in Q3 2018.
  • 335 funds tracked by Wall St. Rank held Ingevity as of Q3 2019.

Based on Dorsey & Whitney Trust's 13F filing for Q3 2019, filed 8 Nov 2019.